BYAH

Index	-	P/E	-	EPS (ttm)	-41.38	Insider Own	96.99%	Shs Outstand	33.87M	Perf Week	-19.85%
Market Cap	3.51M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.02M	Perf Month	0.46%
Enterprise Value	-0.10M	PEG	-	EPS next Q	-	Inst Own	0.00%	Short Float	2.42%	Perf Quarter	-57.34%
Income	-24.36M	P/S	1.39	EPS this Y	-	Inst Trans	27.46%	Short Ratio	0.24	Perf Half Y	-92.01%
Sales	2.52M	P/B	0.18	EPS next Y	-	ROA	-539.29%	Short Interest	0.02M	Perf YTD	-86.29%
Book/sh	5.90	P/C	0.93	EPS next 5Y	-	ROE	-885.84%	52W High	2074.50 -99.95%	Perf Year	-99.85%
Cash/sh	1.18	P/FCF	-	EPS past 3/5Y	- -	ROIC	-598.53%	52W Low	0.93 17.19%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	9.57% -	Gross Margin	90.64%	Volatility	13.65% 8.90%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-0.04	EPS Y/Y TTM	-5179.86%	Oper. Margin	-956.45%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.88	Sales Y/Y TTM	6.00%	Profit Margin	-965.00%	RSI (14)	41.63	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.92	EPS Q/Q	-1140.53%	SMA20	-8.48%	Beta	-0.46	Target Price	-
Payout	-	Debt/Eq	0.05	Sales Q/Q	-15.91%	SMA50	-3.41%	Rel Volume	0.21	Prev Close	1.21
Employees	41	LT Debt/Eq	0.02	Earnings	-	SMA200	-90.69%	Avg Volume	100.97K	Price	1.09
IPO	Dec 27, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	21,374	Change	-9.92%

Jan-28-26 04:10PM	Park Ha Biological Technology Co., Ltd. Announces Closing of a US$2.45 Million Public Offering (GlobeNewswire) +12.61% -23.60%
Jan-27-26 08:30AM	Park Ha Biological Technology Co., Ltd. Announces Pricing of US$2.45 Million Best-Efforts Follow-on Public Offering (GlobeNewswire) -24.08%
Oct-24-25 09:26AM	Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH (GlobeNewswire) +5.39%
Aug-18-25 12:00AM	I almost fell off my chair: Investors lose billions on meme stocks as pump and dump scams multiply (Financial Times)
Apr-30-25 06:21AM	Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025 (Insider Monkey)
05:03AM	Loading…
Mar-31-25 05:03AM	Park Ha Biological Technology: Growth Potential And Profitability Concerns (Seeking Alpha)
Mar-25-25 09:24AM	Why Park Ha Biological Technology Co Ltd (PHH) Is Surging In 2025? (InsiderMonkey) -11.83%
Mar-09-25 06:02PM	Why Park Ha Biological Technology Co., Ltd. (PHH) Soared Last Week (Insider Monkey)
Jan-06-25 08:00AM	D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering (GlobeNewswire) +7.05%
Dec-30-24 05:30PM	Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering (GlobeNewswire) +19.16% +29.69%
Dec-26-24 09:46PM	Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering (GlobeNewswire)

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. It operates through the Product Sales and Franchise Fees segments. The company was founded by Xiao Qiu Zhang on October 11, 2022 and is headquartered in Wuxi, China.

CEO & Chairman of the BoardMs. Xiaoqiu Zhang

Chief Financial OfficerMs. Xiaoyan Zhu

CTO & Product ManagerMs. Xinyu Li

Park Ha Biological Technology Co Ltd

Upgrade your Finviz experience